Treace Medical Concepts, Inc.
TMCI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 11.9% | 31.9% | 50.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 80.4% | 81.2% | 80.6% | 82.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -20.1% | -20.8% | -25.6% | -16.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -26.6% | -26.5% | -30.2% | -21.8% |
| EPS Diluted | -0.9 | -0.81 | -0.77 | -0.38 |
| % Growth | -11.1% | -5.2% | -102.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |